Aggressive lymphoma: Low doses of approved drug switches on pathway that allows chemotherapy to kill cancer




Patients with an aggressive lymphoma that often relapses and kills within two years experienced a remission of their cancer and stayed disease-free as long as 28 months after taking a commercially-available drug that made chemotherapy more effective.

Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/j...

Viernes, 16 de Agosto 2013
Jueves, 1 de Enero 1970
1

1 1
Otros artículos de esta sección